The Role of B Cells in Multiple Sclerosis: Implications for B-Cell-Targeted Therapy

E-ISSN： 1875-533x|17|28|3215-3222

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.28, 2010-09, pp. : 3215-3222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

B-Cell-Targeted Therapy for Systemic Lupus Erythematosus

By Sabahi Ramin Anolik Jennifer H.

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 1933-1948

Adis International

Access to resources Recommend Favorite

The Potential Role of B Cell-Targeted Therapies in Multiple Sclerosis

By Boster Aaron Ankeny Daniel P. Racke Michael K.

Drugs, Vol. 70, Iss. 18, 2010-12 ,pp. : 2343-2356

Adis International

Access to resources Recommend Favorite

Benefit-risk assessment of interferon-b therapy for relapsing multiple sclerosis

By Francis Gordon

Expert Opinion on Drug Safety, Vol. 3, Iss. 4, 2004-07 ,pp. : 289-303

Informa Healthcare

Access to resources Recommend Favorite

B Cell-Targeted Therapy for Rheumatoid Arthritis: An Update on the Evidence

By Looney R. John

Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. : 625-639

Adis International

Access to resources Recommend Favorite

Molecular Approach to Targeted Therapy for Multiple Sclerosis

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 1, 2016-02 ,pp. : 20-34

Bentham Science Publishers

Access to resources Recommend Favorite